BKR Reiterate Buy and $74 PT after results - EBITDA Exceeds Consensus by 9.4%; Robust IET Orders and 28% Increase in 2026 IET Order Guidance
BKR Reiterate Buy and $74 PT after results - EBITDA Exceeds Consensus by 9.4%; Robust IET Orders and 28% Increase in 2026 IET Order Guidance @ Stifel
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.